A study fully illustrated the role of Hh signaling in EGFR mutant lung cancer, their result showed that, through the induction of mesenchymal properties, Hh could mediate the resistance of EGFR inhibitors (110). The gene discussed is EGFR; the disease is lung carcinoma.